HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease.

Abstract
The recent identification of neurotrophic factors, such as the glial cell line derived neurotrophic factor (GDNF), acting on mesencephalic dopaminergic neurons, offers the possibility to stimulate the axonal regeneration of these cells which are affected in Parkinson's disease. Nevertheless, a safe and efficient GDNF delivery system that may be used in clinical trials is still lacking. We have developed GDNF-releasing microspheres capable of releasing the neurotrophic factor for at least 2 months in vivo. In this study we demonstrate that these microspheres, when implanted in the brains of 'Parkinsonian' rats, were well tolerated, and were able to induce sprouting of the preserved dopaminergic fibers with synaptogenesis. Moreover, this neural regeneration was accompanied by functional improvement. The implantation of GDNF-releasing microspheres could be a promising strategy in the treatment of Parkinson's disease.
AuthorsChristophe Jollivet, Anne Aubert-Pouessel, Anne Clavreul, Marie Claire Venier-Julienne, Séverine Remy, Claudia N Montero-Menei, Jean Pierre Benoit, Philippe Menei
JournalBiomaterials (Biomaterials) Vol. 25 Issue 5 Pg. 933-42 (Feb 2004) ISSN: 0142-9612 [Print] Netherlands
PMID14609682 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Coated Materials, Biocompatible
  • Drug Carriers
  • Drug Implants
  • Gdnf protein, rat
  • Glial Cell Line-Derived Neurotrophic Factor
  • Nerve Growth Factors
  • Oxidopamine
Topics
  • Absorbable Implants
  • Animals
  • Coated Materials, Biocompatible (chemistry)
  • Corpus Striatum (drug effects, surgery)
  • Drug Carriers (chemistry)
  • Drug Implants (chemistry)
  • Feasibility Studies
  • Female
  • Glial Cell Line-Derived Neurotrophic Factor
  • Microspheres
  • Nerve Growth Factors (administration & dosage)
  • Oxidopamine
  • Parkinsonian Disorders (chemically induced, diagnosis, drug therapy)
  • Rats
  • Rats, Sprague-Dawley
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: